ALEC
Price
$1.65
Change
+$0.13 (+8.55%)
Updated
Jul 9 closing price
Capitalization
164.99M
21 days until earnings call
CTXR
Price
$1.77
Change
-$0.16 (-8.29%)
Updated
Jul 9 closing price
Capitalization
19.78M
Interact to see
Advertisement

ALEC vs CTXR

Header iconALEC vs CTXR Comparison
Open Charts ALEC vs CTXRBanner chart's image
Alector
Price$1.65
Change+$0.13 (+8.55%)
Volume$565.5K
Capitalization164.99M
Citius Pharmaceuticals
Price$1.77
Change-$0.16 (-8.29%)
Volume$1.53M
Capitalization19.78M
ALEC vs CTXR Comparison Chart in %
Loading...
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALEC vs. CTXR commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALEC is a StrongBuy and CTXR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (ALEC: $1.65 vs. CTXR: $1.77)
Brand notoriety: ALEC and CTXR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALEC: 69% vs. CTXR: 45%
Market capitalization -- ALEC: $164.99M vs. CTXR: $19.78M
ALEC [@Biotechnology] is valued at $164.99M. CTXR’s [@Biotechnology] market capitalization is $19.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALEC’s FA Score shows that 0 FA rating(s) are green whileCTXR’s FA Score has 1 green FA rating(s).

  • ALEC’s FA Score: 0 green, 5 red.
  • CTXR’s FA Score: 1 green, 4 red.
According to our system of comparison, CTXR is a better buy in the long-term than ALEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALEC’s TA Score shows that 4 TA indicator(s) are bullish while CTXR’s TA Score has 5 bullish TA indicator(s).

  • ALEC’s TA Score: 4 bullish, 3 bearish.
  • CTXR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both ALEC and CTXR are a good buy in the short-term.

Price Growth

ALEC (@Biotechnology) experienced а +10.00% price change this week, while CTXR (@Biotechnology) price change was -15.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +12.58%. For the same industry, the average monthly price growth was +16.60%, and the average quarterly price growth was +18.46%.

Reported Earning Dates

ALEC is expected to report earnings on Nov 11, 2025.

CTXR is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+12.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALEC($165M) has a higher market cap than CTXR($19.8M). ALEC YTD gains are higher at: -12.698 vs. CTXR (-55.750). CTXR has higher annual earnings (EBITDA): -42.77M vs. ALEC (-137.59M). ALEC has more cash in the bank: 355M vs. CTXR (26.4K). CTXR has less debt than ALEC: CTXR (932K) vs ALEC (41M). ALEC has higher revenues than CTXR: ALEC (88.3M) vs CTXR (0).
ALECCTXRALEC / CTXR
Capitalization165M19.8M833%
EBITDA-137.59M-42.77M322%
Gain YTD-12.698-55.75023%
P/E RatioN/AN/A-
Revenue88.3M0-
Total Cash355M26.4K1,344,697%
Total Debt41M932K4,399%
FUNDAMENTALS RATINGS
ALEC vs CTXR: Fundamental Ratings
ALEC
CTXR
OUTLOOK RATING
1..100
933
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
9
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
5536
P/E GROWTH RATING
1..100
94100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CTXR's Valuation (9) in the Pharmaceuticals Major industry is somewhat better than the same rating for ALEC (51) in the Biotechnology industry. This means that CTXR’s stock grew somewhat faster than ALEC’s over the last 12 months.

CTXR's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as ALEC (100) in the Biotechnology industry. This means that CTXR’s stock grew similarly to ALEC’s over the last 12 months.

CTXR's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as ALEC (100) in the Biotechnology industry. This means that CTXR’s stock grew similarly to ALEC’s over the last 12 months.

CTXR's Price Growth Rating (36) in the Pharmaceuticals Major industry is in the same range as ALEC (55) in the Biotechnology industry. This means that CTXR’s stock grew similarly to ALEC’s over the last 12 months.

ALEC's P/E Growth Rating (94) in the Biotechnology industry is in the same range as CTXR (100) in the Pharmaceuticals Major industry. This means that ALEC’s stock grew similarly to CTXR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALECCTXR
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 8 days ago
85%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TPH34.151.56
+4.79%
Tri Pointe Homes
SYNX1.680.02
+1.20%
Silynxcom Ltd
HFFG3.280.02
+0.61%
HF Foods Group
IRS14.47-0.07
-0.48%
IRSA Inversiones Y Representaciones S.A
WIT3.07-0.02
-0.65%
Wipro Limited